LDS/Medical Tests/Inhibin A

Inhibin A

Inhibins are heterodimeric glycoprotein hormones secreted by the granulosa cells of the ovary in females and the Sertoli cells in the male testis. Inhibins selectively suppress the secretion of follicle stimulating hormone (FSH) from the pituitary gland and have also been shown to have local action within the gonads.

Inhibin is a 32-kDalton protein consisting of α and ΒA protein chains that are covalently joined by disulfide bonds. A bimodal increase of serum inhibin-A concentration is typically observed during normal pregnancy. Concentrations increase during the first trimester, decline after ten weeks, remain stable between 15-25 weeks of gestation and then again increases, peaking at term. Total Inhibin A concentration is typically elevated if the fetus is affected by Down syndrome. Concentration may also be affected by gestational age, maternal weight, the number of fetuses, and preeclampsia.

Inhibin-A has also been reported to have clinical application as an adjunct to monitoring of ovarian granulosa cell tumors and mucinous epithelial neoplasms, as well as in reproductive physiology.

The inhibin-A assay utilizes a pair of highly characterized monoclonal antibodies in a two-site immunoassay that essentially eliminates the interference of inactive free α-monomer.

  • As an aid in the diagnosis and monitoring of various hormonal reproductive disorders
  • As an aid during the second trimester as part of the maternal serum quadruple screen
  • As an aid in the diagnosis of preeclamptic toxemia
  • As an aid in the diagnosis of ovarian (granulosa cell) tumors
  • Aids evalation of ovarian mucinous epithelial tumors
  • Though not cleared for use, published studies suggest Inhibin-A may have clinical application as an adjunct to the monitoring of ovarian granulosa cell tumors, as well as in reproductive physiology

Increased in:

  • Pregnancy with gestational age
  • Ovarian granulosa cell tumors and some mucinous epithelial neoplasms
  • Some Preeclampsia

Units: pg/mL

Group pg/mL
Adult Males 1.0–3.6

 

Nonpregnant Adult Females
Physiologic State pg/mL
early follicular phase 5.5–28.2
Mid follicular phase 7.9–34.5
Late follicular phase 19.5–102.3
Mid cycle 49.9–155.5
Early luteal phase 35.9–132.7
Mid luteal phase 13.2–159.6
Late luteal phase 7.3–89.9
IVF – peak levels 354.2–1690.0
PCOS – ovulatory 5.7–16.0
Postmenopausal 1.0–3.9

Electrochemiluminescence immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA).

Serum (SST).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days
AFP, HCG, Unconjugated Estriol for Prenatal Screening, Acetylcholinesterase, AFP from Amniotic Fluid, Amniocentesis or Chorionic Villi Sampling for Chromosomal Analysis, CA 19-9, CEA, HCG, Pregnancy Associated Protein A.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login